- Home
- GLDD vs IMTX Comparison
GLDD vs IMTX Comparison
Compare GLDD & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLDD
- IMTX
- Stock Information
- Founded
- GLDD 1890
- IMTX N/A
- Country
- GLDD United States
- IMTX Germany
- Employees
- GLDD N/A
- IMTX N/A
- Industry
- GLDD Military/Government/Technical
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GLDD Industrials
- IMTX Health Care
- Exchange
- GLDD Nasdaq
- IMTX Nasdaq
- Market Cap
- GLDD 829.6M
- IMTX 954.2M
- IPO Year
- GLDD 2006
- IMTX N/A
- Fundamental
- Price
- GLDD $11.95
- IMTX $7.15
- Analyst Decision
- GLDD Buy
- IMTX Strong Buy
- Analyst Count
- GLDD 1
- IMTX 4
- Target Price
- GLDD $14.00
- IMTX $16.67
- AVG Volume (30 Days)
- GLDD 409.1K
- IMTX 522.7K
- Earning Date
- GLDD 11-05-2024
- IMTX 11-18-2024
- Dividend Yield
- GLDD N/A
- IMTX N/A
- EPS Growth
- GLDD N/A
- IMTX N/A
- EPS
- GLDD 0.87
- IMTX N/A
- Revenue
- GLDD $741,648,000.00
- IMTX $128,824,447.00
- Revenue This Year
- GLDD $33.01
- IMTX $90.79
- Revenue Next Year
- GLDD $6.88
- IMTX N/A
- P/E Ratio
- GLDD $13.52
- IMTX N/A
- Revenue Growth
- GLDD 33.74
- IMTX 52.53
- 52 Week Low
- GLDD $6.55
- IMTX $6.99
- 52 Week High
- GLDD $12.89
- IMTX $13.77
- Technical
- Relative Strength Index (RSI)
- GLDD 43.17
- IMTX 27.93
- Support Level
- GLDD $11.70
- IMTX $6.99
- Resistance Level
- GLDD $12.14
- IMTX $7.40
- Average True Range (ATR)
- GLDD 0.31
- IMTX 0.30
- MACD
- GLDD -0.11
- IMTX -0.00
- Stochastic Oscillator
- GLDD 21.01
- IMTX 10.46
About GLDD Great Lakes Dredge & Dock Corporation
Great Lakes Dredge & Dock Corp is a provider of dredging services in the United States. Dredging involves the enhancement or preservation of the navigability of waterways or the protection of shorelines through the removal or replenishment of soil, sand, or rock. Its project portfolio includes Coastal Restoration, Coastal Protection, Ports and Harbors, International, and Inland Dredging.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.